Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial

Yara L Verschoor; Joris van de Haar; José G van den Berg; Johanna W van Sandick; Liudmila L Kodach; Jolanda M van Dieren; Sara Balduzzi; Cecile Grootscholten; Marieke E IJsselsteijn; Alexander A F A Veenhof; Koen J Hartemink; Marieke A Vollebergh; Adham Jurdi; Shruti Sharma; Erik Spickard; Emilia C Owers; Annemarieke Bartels-Rutten; Peggy den Hartog; Noel F C C de Miranda; Monique E van Leerdam; John B A G Haanen; Ton N Schumacher; Emile E Voest; Myriam Chalabi

doi:10.1038/s41591-024-02898-8

Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial

Nat Med. 2024 May;30(5):1499. doi: 10.1038/s41591-024-02898-8.

Authors

Yara L Verschoor¹, Joris van de Haar^#^{2

3}, José G van den Berg^#⁴, Johanna W van Sandick⁵, Liudmila L Kodach⁴, Jolanda M van Dieren¹, Sara Balduzzi⁶, Cecile Grootscholten¹, Marieke E IJsselsteijn⁷, Alexander A F A Veenhof⁵, Koen J Hartemink⁵, Marieke A Vollebergh^{1

8}, Adham Jurdi⁹, Shruti Sharma⁹, Erik Spickard⁹, Emilia C Owers¹⁰, Annemarieke Bartels-Rutten¹¹, Peggy den Hartog¹, Noel F C C de Miranda⁷, Monique E van Leerdam^{1

12}, John B A G Haanen^{8

13

14}, Ton N Schumacher^{2

3

15}, Emile E Voest^{1

2

3}, Myriam Chalabi^{16

17}

Affiliations

¹ Department of Gastrointestinal Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
² Department of Molecular Oncology and Immunology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
³ Oncode Institute, Amsterdam, the Netherlands.
⁴ Department of Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
⁵ Department of Surgery, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
⁶ Biometrics department, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
⁷ Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
⁸ Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
⁹ Natera, Inc, Austin, TX, USA.
¹⁰ Department of Nuclear Medicine, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
¹¹ Department of Radiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
¹² Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
¹³ Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
¹⁴ Oncology Service, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
¹⁵ Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands.
¹⁶ Department of Gastrointestinal Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. m.chalabi@nki.nl.
¹⁷ Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. m.chalabi@nki.nl.

^# Contributed equally.

No abstract available

Publication types

Published Erratum